Detailed price information for Gilead Sciences Inc (GILD-Q) from The Globe and Mail including charting and trades.
Cantor Fitzgerald analyst Kristen Kluska initiated coverage of DBV Technologies (DBVT) with an Overweight rating and $42 price target Published ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback